Skip to main content
. 2020 Oct 16;102:226–232. doi: 10.1016/j.ijid.2020.10.024

Table 3.

Patients age, gender, admitting facility and clinical presentation by final outcome N = 1802


Variable
Recovered n = 1725
Freq.(%)
Died n = 73
Freq.(%)
Total N = 1798
Freq.(%)
Chi-square P-value
Age (in years)
<10 48(100) 0 (0.0) 48(100.0) 173.14 0.000
10-19 55(98.2) 1 (1.8) 56(100.0)
20-29 294(98.7) 4 (1.3) 298(100.0)
30-39 529(99.1) 5 (0.9) 534(100.0)
40-49 444(98.0) 9(2.0) 453(100.0)
50-59 234(92.5) 19(7.5) 253(100.0)
60-69 83(81.4) 19(18.6) 102(100.0)
70-79 23(69.7) 10(30.3) 33(100.0)
80 and older 15(71.4) 6(28.6) 21(100.0)
Mean (SD) 41.7(15.0) 61.2(17.1) 42.5(15.6) -10.8 0.000
Gender
Female 611(97.3) 17 (2.7) 628(100.0) 4.54 0.033
Male 1114(95.2) 56 (4.8) 1,170(100.0)
Admitting facility (n = 1802)
Government-owned 1689(96.2) 66 (3.8) 1,755(100.0) 16.9 0.00
Privately run 36(83.7) 7 (16.3) 43(100.0)
The presence of symptoms at presentation
Symptomatic 1092(99.1) 10(0.9) 1102(100.0) 72.64 0.000
Asymptomatic 633(91.0) 63(9.0) 696(100.0)
Initial presentation
Mild 1,089(99.6) 4 (0.4) 1,093(100.0) 981.177 0.000
Moderate 584(97.3) 16 (2.7) 600(100.0)
Severe 52(76.5) 16(23.5) 68(100.0)
Critical 0(0.0) 37(100.0) 37(100.0) 0.000
Prescence of co-morbidity
Yes 336(86.8) 51(13.2) 387(100.0) 105.26 0.000
No 1389(98.4) 22(1.6) 1411(100.0)
Number of co-morbidities (n = 387)
1 270(91.2) 26(8.8) 296(100.0)
2 61(72.6) 23(27.4) 84(100.0)
3 or more 5(71.4) 2(28.6) 7(100.0) 21.26 0.000